In Depth 11 Dec 2024
Targeting sugar molecules: Can glycobiology lead to a new era for cancer immunotherapy?
Find out more about the emerging field of glycobiology, which could potentially lead to a new type of cancer immunotherapy.
- Latest Posts
Antibody Therapy R&D trends and breakthrough innovations
Check out a new report exploring R&D trends and breakthrough innovations leveraging antibodies to create potentially game-changing therapies, published by our parent company Inpart.
More News! 10 Dec 2024
Biotech in 2024: A retrospective
2024 is coming to a close and it is time to look at how biotech performed this year. Was it a triumph or a year of cautious optimism?
In Depth 9 Dec 2024
CAR-T cell therapy for lupus: An emerging field with great potential
Discover how the emerging field of using CAR-T cell therapy to treat lupus could offer a potential cure for the autoimmune disorder.
Podcast 6 Dec 2024
Cracking the code of biotech valuations
Our guest on the podcast this week to discuss the biotech scene in Eastern Europe, and look at some of the challenges facing biotech companies is Adam Marťák, CEO of ambiom.
In Depth 5 Dec 2024
The biggest private biotech investments in November 2024
The companies Metsera, Alentis Therapeutics, and Adcendo bagged the biggest private biotech investments in November 2024.
ADVERTISEMENT
ADVERTISEMENT
Best in Biotech 5 Dec 2024
Five biosimilar companies you should know about
Discover five biosimilar companies creating affordable versions of blockbuster drugs and hoping to capitalize on the upcoming patent cliff.
In Depth 4 Dec 2024
Idiopathic pulmonary fibrosis: Refoxy, Boehringer, Insilico, and more on the hunt for curative treatments
There is a lot of research going on in the therapeutic field of idiopathic pulmonary fibrosis, in the hope that more treatments reach patients sooner.
Best in Biotech 3 Dec 2024
Twelve gift ideas for a biotech enthusiast this holiday season
Explore our curated list of biotechnology-themed gifts, ranging from captivating board games to engaging DIY biology kits.
Process intensification: Fueling biopharma success at warp speed
Learn about process intensification in biopharma, key strategies for success, and solutions to overcome manufacturing challenges.
In Depth 2 Dec 2024
The rise of cancer vaccines: A new era in immunotherapy
Delve into the expanding and diverse field of cancer vaccines with various approaches exploiting the immune system to fight tumors.
News and Trends 29 Nov 2024
Trump’s healthcare picks: Who they are and what they mean for the biopharma industry
Trump’s nominees for top healthcare roles have sparked significant debate. So, what do their appointments signal for the future of healthcare in the U.S.?
ADVERTISEMENT
